The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients With Non-Muscle Invasive Bladder Cancer.

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-3850